Phase 2–4 trials
Neuroscience · Live ClinicalTrials.gov data
Lecanemab (Leqembi) clinical trial pipeline
ClinicalTrials.gov lists 13 phase 2–4 trials for lecanemab (Leqembi), 3 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2026. Refreshed daily. Add up to four competitors to compare pipelines side by side.
Phase 3 trials
Actively recruiting
Next phase 3 primary completion
Participants across trials
Lead sponsor by trial count
lecanemab
Upcoming readouts
10 ahead · lecanemab
Key lecanemab trials
Top 12 of the 13 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track lecanemab with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for lecanemab?
- ClinicalTrials.gov currently lists 13 phase 2–4 lecanemab trials: 6 phase 2, 4 phase 3, and 3 phase 4. 3 are actively recruiting.
- Are there clinical trials for Leqembi?
- Leqembi is the brand name for lecanemab, so lecanemab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 13 phase 2–4 lecanemab trials: 6 phase 2, 4 phase 3, and 3 phase 4. 3 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare lecanemab against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
